Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment

The increased use of immune-checkpoint inhibitors to treat various types of cancer has increased the incidence of immune-related adverse events (irAEs). Hepatic irAEs are frequent and can lead to serious conditions. Among the various types of hepatic irAEs reported to date, bile duct injury has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Murayama, Aiko, Tajiri, Kazuto, Nakaya, Atsuko, Ito, Hiroyuki, Hayashi, Yuka, Entani, Toshiki, Nagata, Kohei, Tanaka, Shinichi, Hamashima, Takeru, Yasuda, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case and Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454244/
https://www.ncbi.nlm.nih.gov/pubmed/34616270
http://dx.doi.org/10.1159/000516199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454244/
https://www.ncbi.nlm.nih.gov/pubmed/34616270
http://dx.doi.org/10.1159/000516199

Ejemplares similares